Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Solid Organ Cancers”

84 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 84 results

Testing effectiveness (Phase 2)Looking for participantsNCT06909110
What this trial is testing

Viral Specific T-Lymphocytes to Treat Infection With Adenovirus, Cytomegalovirus or Epstein-Barr Virus in Patients With Compromised Immunity

Who this might be right for
AdenovirusCytomegalovirus InfectionsEpstein-Barr Virus Infections
Jessie L. Alexander 25
Early research (Phase 1)UnknownNCT02575638
What this trial is testing

Safety Study of Camptothecin-20-O-Propionate Hydrate (CZ48)

Who this might be right for
Malignant Lymphoma of Extranodal and/or Solid Organ SiteSolid Tumor
Cao Pharmaceuticals Inc. 65
Not applicableLooking for participantsNCT05284877
What this trial is testing

The Organ Transplant Recipient HPV and Skin Cancer Study

Who this might be right for
Solid Organ Transplant RecipientSkin CancerSkin Dysplasia+4 more
Merete Haedersdal 1,500
Large-scale testing (Phase 3)Study completedNCT00296036
What this trial is testing

Pyridoxine and Topical Urea/Lactic Acid-Based Cream in Preventing Hand-Foot Syndrome in Patients Receiving Capecitabine for Breast Cancer or Other Cancer

Who this might be right for
Breast CancerDrug/Agent Toxicity by Tissue/OrganUnspecified Adult Solid Tumor, Protocol Specific
Alliance for Clinical Trials in Oncology 137
Not applicableStudy completedNCT01576653
What this trial is testing

Prospective Clinical Evaluation of Beta-D-Glucan Assay in Blood and BAL

Who this might be right for
Invasive Fungal InfectionHematological MalignancyReceipt of Solid Organ Transplant
Robert Krause, MD 100
Not applicableStudy completedNCT04844489
What this trial is testing

Study of the Humoral Response to SARS-CoV-2 Variants and of the Cellular Response After Vaccination Against COVID-19 in Immunocompromised People

Who this might be right for
Autoimmune or Autoinflammatory DiseasesHIVMultiple Sclerosis+2 more
Assistance Publique - Hôpitaux de Paris 377
Testing effectiveness (Phase 2)Looking for participantsNCT06427460
What this trial is testing

Central-boost Ablative Radiation Therapy for Solid Tumors (CBART)

Who this might be right for
Pancreatic Cancer
Changhai Hospital 67
Large-scale testing (Phase 3)Study completedNCT00003600
What this trial is testing

Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy

Who this might be right for
AnemiaBreast CancerChronic Myeloproliferative Disorders+8 more
Alliance for Clinical Trials in Oncology 344
Early research (Phase 1)UnknownNCT00024310
What this trial is testing

Paclitaxel, Folic Acid, and Lometrexol in Treating Patients With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganUnspecified Adult Solid Tumor, Protocol Specific
Jonsson Comprehensive Cancer Center
Not applicableLooking for participantsNCT06792604
What this trial is testing

Host Genome Methylation: a Screening Tool in Anal Cancer Detection

Who this might be right for
Anal Cancer
Assistance Publique - Hôpitaux de Paris 770
Not applicableStudy completedNCT00948883
What this trial is testing

Study of Cancers After Solid Organs Transplants

Who this might be right for
CancerOrgan Transplantation
Assistance Publique - Hôpitaux de Paris 330
Large-scale testing (Phase 3)Looking for participantsNCT03394365
What this trial is testing

Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy

Who this might be right for
Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD)Solid Organ Transplant ComplicationsLymphoproliferative Disorders+2 more
Pierre Fabre Medicament
Testing effectiveness (Phase 2)Study completedNCT01058239
What this trial is testing

Bortezomib Plus Rituximab for EBV+ PTLD

Who this might be right for
Post-transplant Lymphoproliferative DiseaseSolid Organ TransplantStem Cell Transplant (Bone Marrow Transplant)+1 more
Massachusetts General Hospital 7
Not applicableStudy completedNCT03685539
What this trial is testing

DECT in Imaging Patients With Solid Organ Cancer With Intracranial Metastasis

Who this might be right for
Malignant NeoplasmMetastatic Malignant Neoplasm in the Brain
M.D. Anderson Cancer Center 42
Post-approval studies (Phase 4)UnknownNCT02444936
What this trial is testing

ZOSTAVAX in Persons Imminently Receiving Chemotherapy for Solid Organ Tumors

Who this might be right for
Shingles
Louis Stokes VA Medical Center 22
Early research (Phase 1)Study completedNCT00026169
What this trial is testing

Imatinib Mesylate in Treating Patients With Advanced Cancer and Kidney Failure

Who this might be right for
Malignant NeoplasmUnspecified Adult Solid Tumor, Protocol Specific
National Cancer Institute (NCI) 69
Early research (Phase 1)Study completedNCT00054483
What this trial is testing

Bortezomib in Treating Patients With Advanced Cancer and Kidney Dysfunction

Who this might be right for
Adult Grade III Lymphomatoid GranulomatosisAdult Nasal Type Extranodal NK/T-cell LymphomaExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue+31 more
National Cancer Institute (NCI) 69
Not applicableStudy completedNCT03868046
What this trial is testing

Autoantibodies in Treatment with Immune Checkpoint Inhibitors (AUTENTIC)

Who this might be right for
CancerMetastatic CancerSolid Organ Cancer
Hospital Universitario Araba 242
Testing effectiveness (Phase 2)Ended earlyNCT04364178
What this trial is testing

Viral Specific T-Lymphocytes to Treat Adenovirus, CMV and EBV

Who this might be right for
AdenovirusCytomegalovirus InfectionsEpstein-Barr Virus
Jessie L. Alexander, MD 8
Early research (Phase 1)Temporarily pausedNCT06741072
What this trial is testing

BZLF1 Peptide Vaccine (OSU-2131) With QS-21 for the Prevention of Epstein-Barr Virus Related Cancer in Patients Awaiting Solid Organ Transplants

Who this might be right for
Chronic Kidney Disease, Stage 4Chronic Kidney Disease, Stage 5EBV-Related Lymphoproliferative Disorder+2 more
Ohio State University Comprehensive Cancer Center 55
Load More Results
115